Alnylam Pharmaceuticals Inc
NASDAQ:ALNY 4:00:00 PM EDT
Market Cap (Intraday) | 18.92B |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $150.39 |
50-Day MA | $149.34 |
200-Day MA | $170.06 |
Alnylam Pharmaceuticals Inc Stock, NASDAQ:ALNY
675 West Kendall Street, Henri A. Termeer Square, Cambridge, Massachusetts 02142
United States of America
Phone: +1.617.551.8200
Number of Employees: 2100
Description
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002 and is headquartered in Cambridge, MA.